(lp0
S"Better Buy: Medivation, Inc. vs. Inovio Pharmaceuticals, Inc. Motley Fool - Jul 12, 2016 Medivation  attempted to jump-start a bidding war after rejecting Sanofi's  second acquisition offer."
p1
aS'Why Medivation, Inc. Shares Crashed 32% in January Motley Fool - Feb 3, 2016 What: Ahead of news that the FDA has put a partial clinical hold on a key drug trial, shares in Medivation  dropped 32.4% in January, according to S&amp;P Capital IQ.'
p2
aS"Medivation Inc. Stock Is Rising Today -- Here's Why Motley Fool - Feb 26, 2016 What: Shares of Medivation  were up more than 10% as of 3:00 p.m. ET after the cancer-focused biopharmaceutical company reported its fourth-quarter earnings."
p3
aS"Pfizer to Buy Medivation for $14 Billion Wall Street Journal - Aug 22, 2016 Pfizer Inc. said Monday that it had agreed to buy biotech Medivation Inc. for about $14 billion, in a move that adds one of the crown jewels of the multibillion-dollar market for cancer drugs to Pfizer's portfolio.Pfizer Said Close to $14 Billion Deal to Acquire Medivation - Bloomberg"
p4
aS'Medivation: A Value In Biotech Seeking Alpha - Aug 18, 2016 Medivation  is just such a company which is misunderstood by the market. It is a highly de-risked biotech with a commercialized, blockbuster drug  already providing significant financial resources for the&nbsp;...How Much Medivation Can Really Fetch in a Buyout - 24/7 Wall St.Medivation Inc : Excellent Opportunity to Get Best Price for its ... - TCC'
p5
aS'Better Buy Now: Medivation Inc vs Jazz Pharmaceuticals Motley Fool - Oct 24, 2015 Investors in biotech stocks Jazz Pharmaceuticals PLC  and Medivation  must be smiling from ear to ear, as each of these companies has been a monster winner for long-term investors.'
p6
aS'Tesla Motors Inc. and Medivation Inc. Jump as Stocks Fall Motley Fool - Mar 31, 2016 Medivation spiked 23% higher on heavy trading volume after Bloomberg reported that the biopharmaceutical company has been approached by several potential buyers.'
p7
aS"J&amp;J's Q1 Results Suggest More Upside for Medivation, Inc. Motley Fool - Apr 27, 2016 The loss of market share in this high-profile market suggests that Medivation  and Astellas Pharma's  Xtandi continues to gain ground, and that could mean that Medivation is worth more than it was three months ago."
p8
aS"Report: Medivation Committed To Selling Itself Benzinga - May 10, 2016 Medivation Inc  had an offer on the table to be acquired by Sanofi SA   for $9.3 billion, or $52.50 per share.Exclusive: Medivation succumbs to pressure to explore sale - sources - ReutersWhy Did Medivation's Share Price Increase so Much after Earnings? - Market Realist"
p9
aS"In Wake Of Medivation Deal, Argus Thinks Pfizer's Existing Business Is Underrated Benzinga - Aug 29, 2016 On August 22, Pfizer Inc.  announced it had entered into an agreement to acquire Medivation Inc  for almost $14 billion or $81.50 per shares.Medivation Proxy Shows Pfizer Battled Four Bidders to Seal a Deal - TheStreet.com3 Stocks Up Over 1000% in the Past 5 Years - Motley Fool"
p10
a.